Correlation Between Spyre Therapeutics and Cardinal Health

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Cardinal Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Cardinal Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Cardinal Health, you can compare the effects of market volatilities on Spyre Therapeutics and Cardinal Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Cardinal Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Cardinal Health.

Diversification Opportunities for Spyre Therapeutics and Cardinal Health

-0.35

Correlation Coefficient

Spyre Therapeutics  Cardinal Health

Very good diversification

The 3 months correlation between Spyre and Cardinal is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Cardinal Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardinal Health and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Cardinal Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardinal Health has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Cardinal Health go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Cardinal Health

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Cardinal Health. In addition to that, Spyre Therapeutics is 3.86 times more volatile than Cardinal Health. It trades about -0.12 of its total potential returns per unit of risk. Cardinal Health is currently generating about 0.12 per unit of volatility. If you would invest  11,990  in Cardinal Health on October 11, 2024 and sell it today you would earn a total of  263.00  from holding Cardinal Health or generate 2.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  Cardinal Health

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Cardinal Health

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cardinal Health are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Cardinal Health may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Spyre Therapeutics and Cardinal Health

The main advantage of trading using opposite Spyre Therapeutics and Cardinal Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Cardinal Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardinal Health will offset losses from the drop in Cardinal Health's long position.

The idea behind Spyre Therapeutics and Cardinal Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.